Robert Studholme - 07 Mar 2023 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Reporting relationship: Senior VP, Operations
Issuer ticker: STAA
Reported as of: 07 Mar 2023
Net transaction value: +$99,344
SEC form: 4
Accepted by SEC: 08 Mar 2023, 19:18:08 UTC
Prior SEC filing: 05 Jul 2022
Next SEC filing: 10 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Samuel Gesten as attorney-in-fact for Robert Studholme

Key filing fact

Robert Studholme filed Form 4 for STAAR SURGICAL CO (STAA) on 08 Mar 2023.

Key facts

This page summarizes Robert Studholme's Form 4 filing for STAAR SURGICAL CO (STAA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Mar 2023, 19:18.

Change

Previous filing in this sequence was filed on 05 Jul 2022.
Current net transaction value: +$99,344.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STAA transaction

Common Shares

Options Exercise

Transaction value: $99,344
Shares: +1,709
Change %: +8%
Price: $58.13
Shares after: 23,121
Date: 07 Mar 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Performance Stock Units (PSUs) converted into common shares on a one-to-one basis, with the amount representing the vesting of PSUs awarded on March 7, 2022, with achievement based on the Corporation's satisfaction of pre-established financial metrics.